Hypertension: APOR studies identify patients, outcomes and costs

Abstract

At the Second Annual International Meeting of the Association for Pharmacoeconomics and Outcomes Research [APOR; Philadelphia, US; April 1997 ] a session was held on the identification of patients with hypertension and the costs and outcomes associated with antihypertensive therapies. The results of the studies presented below suggest the economic burden of hypertension is substantial, that there is room for improvement in antihypertensive prescribing, and that appropriate use of such drugs can lead to better health outcomes and considerable cost savings.